MedPath

Effect of transcranial Direct Current Stimulation (small battery operated devices delivering 2mA of current to specific regions of the brain) on cognitive functions and symptoms of depression in patients suffering from depressio

Not Applicable
Conditions
Health Condition 1: F330- Major depressive disorder, recurrent, mildHealth Condition 2: F331- Major depressive disorder, recurrent, moderateHealth Condition 3: F320- Major depressive disorder, singleepisode, mildHealth Condition 4: F321- Major depressive disorder, singleepisode, moderate
Registration Number
CTRI/2019/05/019300
Lead Sponsor
Manipal University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Patients diagnosed with mild and moderate depression according to ICD 10 criteria

2. Patients who are able to give written informed consent to undergo tDCS

3. Patients of either gender

4. Patients who have been administered a stable dose of antidepressants and/or antipsychotic/mood stabilizers for at least 2 weeks

5. At least five years of formal education (primary level)

Exclusion Criteria

1. Psychiatric co-morbidities, which will be ruled out using the MINI PLUS scale (Excluding Tobacco Dependence Syndrome)

2. Patients not willing to give consent

3. Advanced liver, kidney, cardiac or pulmonary diseases

4. Contraindications to tDCS e.g. metal or medical devices implanted in the body

5. Patients with a history of seizures

6. Patients in remission i.e. patients with a baseline HAM-D score of <= 7 and IDS score of <=14

7. Patients with Severe Depression

8. Patients with a history Bipolar disorder

9. Patients on Benzodiazepines at the time of tDCS procedure

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Change in neurocognitive functions in patients receiving tDCSTimepoint: 4 weeks
Secondary Outcome Measures
NameTimeMethod
Reduction in depressive score â?¥50% HAM-D and IDS scores in patients receiving tDCS. <br/ ><br>Timepoint: 4 weeks
© Copyright 2025. All Rights Reserved by MedPath